NORTHBROOK, Ill., Nov. 10, 2010 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced the company will present at two institutional investor conferences in New York on Wednesday, November 17, 2010.
The company will present at the Lazard Capital Markets 7th Annual Healthcare Conference at 10:30 a.m. ET and at the Stephens Fall Investment Conference at 2:30 p.m. ET.
Interested parties can access a webcast of the Lazard Capital Markets presentation, along with presentation slides, at the Investor Relations/Media tab on Nanosphere's web site, www.nanosphere.us. A replay of the webcast will be available for 90 days.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for direct genomic and ultra-sensitive protein detection. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.
The Nanosphere, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4344